相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RNA sequencing for research and diagnostics in clinical oncology
Anton Buzdin et al.
SEMINARS IN CANCER BIOLOGY (2020)
Atlas of RNA sequencing profiles for normal human tissues
Maria Suntsova et al.
SCIENTIFIC DATA (2019)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma
Er Nie et al.
ONCOGENE (2019)
Pathway Instability Is an Effective New Mutation-Based Type of Cancer Biomarkers
Marianna A. Zolotovskaia et al.
FRONTIERS IN ONCOLOGY (2019)
Personalized prescription of imatinib in recurrent granulosa cell tumor of the ovary: case report
Elena Poddubskaya et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2019)
The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma
Diana A. Aderetti et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
Current state of immunotherapy for glioblastoma
Michael Lim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium
Kenneth Aldape et al.
NEURO-ONCOLOGY (2018)
Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugs
Anton Buzdin et al.
SEMINARS IN CANCER BIOLOGY (2018)
Oncobox Bioinformatical Platform for Selecting Potentially Effective Combinations of Target Cancer Drugs Using High-Throughput Gene Expression Data
Maxim Sorokin et al.
CANCERS (2018)
Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma
Elena V. Poddubskaya et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2018)
Biological Role and Therapeutic Targeting of TGF-β3 in Glioblastoma
Katharina Seystahl et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Spatial heterogeneity in medulloblastoma
A. Sorana Morrissy et al.
NATURE GENETICS (2017)
Histologically defined intratumoral sequencing uncovers evolutionary cues into conserved molecular events driving gliomagenesis
Antony Prabhu et al.
NEURO-ONCOLOGY (2017)
Gene expression and molecular pathway activation signatures of MYCN-amplified neuroblastomas
Ivan Petrov et al.
ONCOTARGET (2017)
RNA-Seq differential expression analysis: An extended review and a software tool
Juliana Costa-Silva et al.
PLOS ONE (2017)
Data aggregation at the level of molecular pathways improves stability of experimental transcriptomic and proteomic data
Nicolas Borisov et al.
CELL CYCLE (2017)
Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Mandy L. Y. Sin et al.
CLINICAL CANCER RESEARCH (2017)
The Reactome pathway Knowledgebase
Antonio Fabregat et al.
NUCLEIC ACIDS RESEARCH (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Single-cell sequencing maps gene expression to mutational phylogenies in PDGF- and EGF-driven gliomas
Soeren Mueller et al.
MOLECULAR SYSTEMS BIOLOGY (2016)
A comprehensive profile of recurrent glioblastoma
B. Campos et al.
ONCOGENE (2016)
Study design requirements for RNA sequencing-based breast cancer diagnostics
Arvind Singh Mer et al.
SCIENTIFIC REPORTS (2016)
Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance
Alessia Fidoamore et al.
STEM CELLS INTERNATIONAL (2016)
Glioma Stem Cells: Signaling, Microenvironment, and Therapy
Brandon D. Liebelt et al.
STEM CELLS INTERNATIONAL (2016)
Spatiotemporal Evolution of the Primary Glioblastoma Genome
Jinkuk Kim et al.
CANCER CELL (2015)
RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics
Myron G. Best et al.
CANCER CELL (2015)
The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
Brenda Auffinger et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity
Marc Aubry et al.
ONCOTARGET (2015)
Combinatorial high-throughput experimental and bioinformatic approach identifies molecular pathways linked with the sensitivity to anticancer target drugs
Larisa Venkova et al.
ONCOTARGET (2015)
A method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activation
Artem Artemov et al.
ONCOTARGET (2015)
The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
Brenda Auffinger et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium
Zhenqiang Su et al.
NATURE BIOTECHNOLOGY (2014)
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
Brett E. Johnson et al.
SCIENCE (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
Signaling pathways activation profiles make better markers of cancer than expression of individual genes
Nikolay M. Borisov et al.
ONCOTARGET (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
KEGG OC: a large-scale automatic construction of taxonomy-based ortholog clusters
Akihiro Nakaya et al.
NUCLEIC ACIDS RESEARCH (2013)
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Andrea Sottoriva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Self-Renewal Does Not Predict Tumor Growth Potential in Mouse Models of High-Grade Glioma
Lindy E. Barrett et al.
CANCER CELL (2012)
Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response
Nicholas J. Szerlip et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
Yifang Hu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
PID: the Pathway Interaction Database
Carl F. Schaefer et al.
NUCLEIC ACIDS RESEARCH (2009)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
分享论文
